Skip to search formSkip to main contentSkip to account menu

AG 1517

Known as: AG-1517 
A quinazoline derivative that selectively inhibits EGFR kinase activity and suppresses the growth of psoriatic keratinocytes.
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Quinazolines
Receptor Tyrosine Kinase Inhibition

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Epidermal growth factor enhances TNF-alpha-induced priming of human neutrophils.
The intensity of neutrophil inflammatory response could be rapidly amplified by priming with pro-inflammatory mediators such as… 
2002
2002
Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function
A mutated form of the EGF receptor (EGFRvIII), resulting from deletion of exons 2–7, is an oncogenic protein that is expressed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)